AQUABOUNTY TECHNOLOGIES (AQB) Stock Price & Overview
NASDAQ:AQB • US03842K3095
Current stock price
The current stock price of AQB is 0.885 USD. Today AQB is up by 2.28%. In the past month the price decreased by -4.84%. In the past year, price increased by 38.13%.
AQB Key Statistics
- Market Cap
- 3.434M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -22.82
- Dividend Yield
- N/A
AQB Stock Performance
AQB Stock Chart
AQB Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to AQB. When comparing the yearly performance of all stocks, AQB turns out to be only a medium performer in the overall market: it outperformed 68.88% of all stocks.
AQB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AQB. AQB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AQB Earnings
AQB Forecast & Estimates
For the next year, analysts expect an EPS growth of 86.82% and a revenue growth 43.65% for AQB
AQB Groups
Sector & Classification
AQB Financial Highlights
Over the last trailing twelve months AQB reported a non-GAAP Earnings per Share(EPS) of -22.82. The EPS decreased by -19.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -365.49% | ||
| ROE | -721.82% | ||
| Debt/Equity | 0 |
AQB Ownership
AQB Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.49 | 380.121B | ||
| AMGN | AMGEN INC | 15.48 | 190.443B | ||
| GILD | GILEAD SCIENCES INC | 15.87 | 174.171B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.07 | 113.617B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.62 | 82.171B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 44.06 | 43.596B | ||
| INSM | INSMED INC | N/A | 35.536B | ||
| NTRA | NATERA INC | N/A | 28.801B | ||
| BIIB | BIOGEN INC | 11.43 | 26.972B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.09 | 24.995B | ||
| MRNA | MODERNA INC | N/A | 19.759B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.548B | ||
| INCY | INCYTE CORP | 12.31 | 18.767B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AQB
Company Profile
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Harvard, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2017-01-09. The Company’s technology advances in fish breeding, genetics, and health and nutrition. The company locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system.
Company Info
IPO: 2017-01-09
AQUABOUNTY TECHNOLOGIES
233 Ayer Road Suite 4, Suite 4
Harvard MASSACHUSETTS 01754 US
CEO: Sylvia A. Wulf
Employees: 4
Phone: 19786486000
AQUABOUNTY TECHNOLOGIES / AQB FAQ
Can you describe the business of AQUABOUNTY TECHNOLOGIES?
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Harvard, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2017-01-09. The Company’s technology advances in fish breeding, genetics, and health and nutrition. The company locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system.
What is the stock price of AQUABOUNTY TECHNOLOGIES today?
The current stock price of AQB is 0.885 USD. The price increased by 2.28% in the last trading session.
Does AQUABOUNTY TECHNOLOGIES pay dividends?
AQB does not pay a dividend.
How is the ChartMill rating for AQUABOUNTY TECHNOLOGIES?
AQB has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is AQUABOUNTY TECHNOLOGIES worth?
AQUABOUNTY TECHNOLOGIES (AQB) has a market capitalization of 3.43M USD. This makes AQB a Nano Cap stock.